semaglutide gallstones risk Ozempic® and Gallbladder Problems: What's the Link? Weight-Loss Injections and Gallbladder Risks:

Off-label use is rising as women seek agency over midlife health

Inflammation and the pathogenesis of atrial fibrillation

A Holistic Approach Is Key : GLP-1 agonists should be viewed as part of a comprehensive, multi-faceted treatment plan for obesity

Begge nringsstoffene spiller roller i kroppens naturlige avgiftningsprosesser

Its distinguishing trait is a narrow, clean action on the GH-secretagogue receptor with little activity elsewhere which in the founding pharmacology meant GH went up while cortisol and prolactin stayed near baseline

" Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice " Published in American Journal of Physiology - Endocrinology and Metabolism in 2019 Experimental proof for the paracrine regulation of intestinal GLP-1 secretion by somatostatin, providing background for the development of somatostatin-5-receptor antagonists for diabetes therapy